Integrated, molecular, omics, immunotherapy, metabolic, epigenetic, and clinical database
US11069431B2 · kind B2 · utility
2Cited by
21References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2018 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Nov 13, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H80/00
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The disclosure describes a patient registry data system that can be used to aggregate clinical, molecular, and immune parameters involved in disease initiation, progression, and response to treatment. The disclosure can allow participants, researchers, and physicians to visualize data based on parameters, such as participant demographics and immune system data.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.